Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

440 ARTíCULOS , VIENDO DEL 106 AL 120

PUBMED

BDNF prevents NMDA-induced toxicity in models of Huntington's disease: the effects are genotype specific and adenosine A2A receptor is involved.

Martire A, Pepponi R, Domenici MR, Ferrante A, Chiodi V, Popoli P.

J Neurochem. 2013 Apr;125(2):225-35. doi: 10.1111/jnc.12177.

0

0

0

PUBMED

Reduced cancer incidence in Huntington's disease: record linkage study clue to an evolutionary trade-off?

Turner MR, Goldacre R, Goldacre MJ.

Clin Genet. 2013 Jun;83(6):588-90. doi: 10.1111/cge.12010. No abstract available.

0

0

0

PUBMED

Pharmacological upregulation of PGC1α in oligodendrocytes: implications for Huntington's Disease.

Xiang Z, Krainc D.

J Huntingtons Dis. 2013;2(1):101-5. doi: 10.3233/JHD-130046.

0

0

0

PUBMED

Association between caffeine intake and age at onset in Huntington's disease.

Simonin C, Duru C, Salleron J, Hincker P, Charles P, Delval A, Youssov K, Burnouf S, Azulay JP, Verny C, Scherer C, Tranchant C, Goizet C, Debruxelles S, Defebvre L, Sablonnière B, Romon-Rousseaux M,

Neurobiol Dis. 2013 Oct;58:179-82. doi: 10.1016/j.nbd.2013.05.013.

0

0

0

PUBMED

Psychological well-being in persons affected by Huntington's disease: a comparison of at-risk, prodromal, and symptomatic groups.

Chisholm LZ, Flavin KT, Paulsen JS, Ready R.

J Health Psychol. 2013 Mar;18(3):408-18. doi: 10.1177/1359105312444646.

0

0

0

PUBMED

Microtransplantation of whole ganglionic eminence cells ameliorates motor deficit, enlarges the volume of grafts, and prolongs survival in a rat model of Huntington's disease.

Zhu M, Shu K, Wang H, Li X, Xiao Q, Chan W, Emmanuel B, Jiang W, Lei T.

J Neurosci Res. 2013 Dec;91(12):1563-71. doi: 10.1002/jnr.23282.

0

0

0

PUBMED

Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's disease.

Gluhm S, Goldstein J, Brown D, Van Liew C, Gilbert PE, Corey-Bloom J.

Mov Disord. 2013 Oct;28(12):1744-7. doi: 10.1002/mds.25578.

0

0

0

PUBMED

Histone Deacetylase 4 (HDAC4) Inhibitors: A Promising Treatment for Huntington's Disease.

Abdel-Magid AF.

ACS Med Chem Lett. 2013 Jun 13;4(8):692-3. doi: 10.1021/ml4002216. No abstract available.

0

0

0

PUBMED

Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease.

Edlinger M, Seppi K, Fleischhacker W, Hofer A.

Int Clin Psychopharmacol. 2013 Jul;28(4):214-6. doi: 10.1097/YIC.0b013e328361e145.

0

0

0

PUBMED

nNOS(+) striatal neurons, a subpopulation spared in Huntington's Disease, possess functional NMDA receptors but fail to generate mitochondrial ROS in response to an excitotoxic challenge.

Canzoniero LM, Granzotto A, Turetsky DM, Choi DW, Dugan LL, Sensi SL.

Front Physiol. 2013 May 16;4:112. doi: 10.3389/fphys.2013.00112.

0

0

0

PUBMED

Neurodegenerative disease: altered DNA methylation and RNA splicing could be key mechanisms in Huntington disease.

Wood H.

Nat Rev Neurol. 2013 Mar;9(3):119. doi: 10.1038/nrneurol.2013.23. No abstract available.

0

0

0

PUBMED

Pluripotent hybrid stem cells from transgenic Huntington's disease monkey.

Laowtammathron C, Chan AW.

Methods Mol Biol. 2013;1010:61-77. doi: 10.1007/978-1-62703-411-1_5.

0

0

0

PUBMED

Chorea in the clinical presentation of moyamoya disease: results of surgical revascularization and a proposed clinicopathological correlation.

Ahn ES, Scott RM, Robertson RL Jr, Smith ER.

J Neurosurg Pediatr. 2013 Mar;11(3):313-9. doi: 10.3171/2012.11.PEDS12199.

0

0

0

PUBMED

Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Suchowersky O, Armstrong MJ, Miyasaki J.

Neurology. 2013 Mar 5;80(10):970. doi: 10.1212/WNL.0b013e3182885eb3. No abstract available.

0

0

0

PUBMED

Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease.

Marder K, Gu Y, Eberly S, Tanner CM, Scarmeas N, Oakes D, Shoulson I; Huntington Study Group PHAROS Investigators..

JAMA Neurol. 2013 Nov;70(11):1382-8. doi: 10.1001/jamaneurol.2013.3487.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy